John Hooper

26PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Apr 23, 2026
Scalable Engineering of Bio-Manufactured Extracellular Vesicles for Selective Delivery in Ovarian Cancer Patient-Derived Models.

|Apr 07, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Zhen Zeng, Anastasia Gandini, Rituparna Bhatt

|Jul 05, 2025
Development of a novel malignant colorectal polyp prognostic nomogram.

Andrew P Zammit, Yagiz Alp Aksoy, Ian Brown

|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

Madeline Gough, Kayden K X Kwah, Tashbib Khan

|Jan 08, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells.

Shivam Vora, Saptarshi Chatterjee, Ariel Andrew

|Nov 09, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition.

Shivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar

Pageof 5

Frequent Collaborators

8 joint publications

David Clark

7 joint publications

Andrew D Riddell

7 joint publications

Ian Brown

7 joint publications

Andrew P Zammit